Workflow
AbCellera: A Waiting Game With High Uncertainty
ABCLAbCellera Biologics(ABCL) Seeking Alpha·2024-08-23 08:43
rdegrie/E+ via Getty Images Introduction AbCellera (NASDAQ:ABCL) has dropped 47% since my last look in September. My article took a cautious tone, describing a company whose revenues were falling despite rising R&D expenditures. I concluded with a hold recommendation, recommending a "wait-and-see" strategy for prospective investors. The company’s robust cash position and technological collaborations offer reason for cautious optimism, but this must be balanced against fiscal inefficiencies and market sk ...